Pramipexole Enhances Reward Learning by Preserving Value Estimates

Area of Science:

• Neuroscience
• Pharmacology
• Computational Psychiatry

Background:

• Dopamine D2-like agonists are potential depression treatments, possibly by enhancing reward learning.
• The precise mechanisms of this enhancement remain unclear.
• Reinforcement learning models propose increased reward sensitivity, inverse decision-temperature, or decreased value decay.

Purpose of the Study:

• To investigate the effects of the dopamine D2-like agonist pramipexole on reward learning mechanisms.
• To differentiate between candidate reinforcement learning mechanisms using fMRI.

Main Methods:

• Double-blind, placebo-controlled study with 40 healthy volunteers.
• 2 weeks of pramipexole (1 mg/day) or placebo.
• Probabilistic instrumental learning task and fMRI to assess reward learning, expectation, and prediction errors.

Main Results:

• Pramipexole improved choice accuracy in reward conditions.
• Increased BOLD response in orbital frontal cortex during win expectation.
• Decreased BOLD response to reward prediction errors in ventromedial prefrontal cortex.

Conclusions:

• Pramipexole enhances reward learning by reducing value decay, preserving learned values.
• This mechanism offers a plausible explanation for pramipexole's antidepressant potential.